Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study

Journal of Gastroenterology

Volumn 50, Issue 3, 2015, Pages 350-360

  Tateishi, Ryosuke ^a   Okanoue, Takeshi ^b   Fujiwara, Naoto ^a   Okita, Kiwamu ^c   Kiyosawa, Kendo ^d   Omata, Masao ^e   Kumada, Hiromitsu ^f   Hayashi, Norio ^g   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Saiseikai Imperial Gift Foundation Inc Saiseikai Suita Hospital   (Japan)

^c Ajisu Kyoritsu Hospital   (Japan)

^d Department of Internal Medicine   (Japan)

^e Yamanashi Prefectural Hospital Organization   (Japan)

^f TORANOMON HOSPITAL   (Japan)

^g KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

Alcoholic liver disease; Hepatocellular carcinoma; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Retrospective study

Indexed keywords

AGED; BODY MASS; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMAN; JAPAN; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTICENTER STUDY; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL ANALYSIS;

AGED; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMANS; JAPAN; LIVER CIRRHOSIS, BILIARY; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84931576321     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-014-0973-8     Document Type: Article

References (32)

1. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
3. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336(26):1855–9 [Epub 1997/06/26].
4. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology. 2002;62(Suppl 1):8–17.
5. Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351(15):1521–31 [Epub 2004/10/08].
6. Yokosuka O, Takaguchi K, Fujioka S, Shindo M, Chayama K, Kobashi H, et al. Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection. J Hepatol. 2010;52(6):791–9.
7. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 1995;346(8982):1051–5 [Epub 1995/10/21].
8. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and non-cirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med. 1999;131(3):174–81.
9. Yuen MF, Hou JL, Chutaputti A. Asia Pacific Working Party on Prevention of Hepatocellular C. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol. 2009;24(3):346–53.
10. Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med. 2008;148(11):820–6 [Epub 2008/06/04].
11. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst. 1991;83(24):1820–6 [Epub 1991/12/18].
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38 [Epub 2003/04/25].
13. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004;126(2):460–8.
14. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295–302 [Epub 2006/05/27].
15. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.
16. The committee for revision of the Clinical Practice. Guidelines for Hepatocellular Carcinoma. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2009 update. Hepatol Res. 2010;40(s1):16–47.
17. Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Second English Edition. Tokyo: Kasahara; 2003.
18. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37(9):676–91.
19. Cancer Statistics in Japan. Foundation for Promotion of Cancer Research; 2012 [cited 2013 March 20th]. Available from: http://ganjoho.jp/data/professional/statistics/backnumber/2012/cancer_statistics_2012.pdf.
20. Higuchi S, Matsushita S, Maesato H, Osaki Y. Japan: alcohol today. Addiction. 2007;102(12):1849–62 [Epub 2007/08/08].
21. National Nutrition Survey in Japan. Ministry of Health Labour, and Welfare of Japan; 2012 [20th March]. Available from: http://www.mhlw.go.jp/stf/houdou/2r9852000002q1st-att/2r9852000002q1wo.pdf.
22. Liang Y, Yang Z, Zhong R. Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis. Hepatology. 2012;56(4):1409–17.
23. Sola R, Alvarez MA, Balleste B, Montoliu S, Rivera M, Miquel M, et al. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients. Liver Int. 2006;26(1):62–72.
24. Montano-Loza AJ, Carpenter HA, Czaja AJ. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis. Am J Gastroenterol. 2008;103(8):1944–51 Epub 2008/06/20.
25. Ertle J, Dechene A, Sowa JP, Penndorf V, Herzer K, Kaiser G, et al. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. Int J Cancer. 2011;128(10):2436–43.
26. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4(3):369–80 [Epub 2006/03/11].
27. Kondo R, Nakashima O, Sata M, Imazeki F, Yokosuka O, Tanikawa K, et al. Pathological characteristics of patients who develop hepatocellular carcinoma with negative results of both serous hepatitis B surface antigen and hepatitis C virus antibody. Hepatol Res. 2013.
28. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol. 2008;43(12):967–74.
29. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang. 1992;63(2):107–11.
30. Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology. 2010;51(5):1531–7.
31. Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int. 2009;29(4):502–10 [Epub 2009/01/15].
32. Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, et al. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One. 2011;6(12):e27326.